Literature DB >> 1059629

Certain patterns of karyotype evolution in chronic myelogeneous leukaemia. Chromosome abnormalities in CML.

E L Prigogina, E W Fleischman.   

Abstract

The study of chromosome banding pattern of leukaemic cells in 15 patients with CML revealed t(9;22) in all cases. Similar additional chromosome abnormalities were observed in the terminal stage of the disease in 5 of 9 patients with aneuploid cell lines. The most frequent abnormalities were i(17q) and trisomy 8. The regularities of karyotype evolution in the terminal stage of CML are discussed.

Entities:  

Mesh：

Year:  1975        PMID： 1059629     DOI： 10.1007/bf00291943

Source DB:  PubMed          Journal:  Humangenetik        ISSN： 0018-7348


  12 in total

1.  G banding in cytogenetic study of hemoblastoses.

Authors:  E W Fleischman; E L Prigogina
Journal:  Humangenetik       Date:  1975

Review 2.  Editorial: Do human tumors show a chromosome pattern specific for each etiologic agent?

Authors:  J D Rowley
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

3.  Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Authors:  J D Rowley
Journal:  Nature       Date:  1973-06-01       Impact factor: 49.962

4.  Involvement of chromosomes 8, 9, 19 and 22 in PH1 positive and PH1 negative chronic myelocytic leukemia in the chronic or blastic stage.

Authors:  G Gahrton; J Lindsten; L Zech
Journal:  Acta Med Scand       Date:  1974-11

5.  The karyotype evolution in chronic granulocytic leukaemia--II. The chromosome and karyotype pattern of advanced evolution.

Authors:  B Pedersen
Journal:  Eur J Cancer       Date:  1973-07       Impact factor: 9.162

6.  The karyotype evolution in chronic granulocytic leukaemia--I. The chromosomes gained and lost during initiation of the evolution.

Authors:  B Pedersen
Journal:  Eur J Cancer       Date:  1973-07       Impact factor: 9.162

7.  [Eleven observations on a precise model of karyotype changes in the course of chronic myeloid leukemia].

Authors:  J De Grouchy; C De Nava; J Feingold; G Bilski-Pasquier; J Bousser
Journal:  Eur J Cancer       Date:  1968-10       Impact factor: 9.162

8.  Some current problems of cancer cytogenetics.

Authors:  A Levan
Journal:  Hereditas       Date:  1967       Impact factor: 3.271

9.  Identification of chromosome anomalies in the blastic phase of chronic myelocytic leukemia (CML) by Giemsa- and quinacrine-banding techniques.

Authors:  D K Hossfeld
Journal:  Humangenetik       Date:  1974-07-15

10.  Nonrandom chromosomal abnormalities in hematologic disorders of man.

Authors:  J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205
View more
  7 in total

Review 1.  [Chromosome aberrations and the origin of tumors (author's transl)].

Authors:  H Zankl; K D Zang
Journal:  Klin Wochenschr       Date:  1978-01-01

2.  Chromosomal marker 20q- in cases of osteomyelosclerosis and CML.

Authors:  E W Fleischman; E L Prigogina; M A Volkova; O E Kulagina
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 3.  The chromosomes of man--clinical and biologic significance. A review.

Authors:  J J Yunis; M E Chandler
Journal:  Am J Pathol       Date:  1977-08       Impact factor: 4.307

4.  Karyotype peculiarities of malignant lymphomas.

Authors:  E W Fleischman; E L Prigogina
Journal:  Hum Genet       Date:  1977-03-14       Impact factor: 4.132

5.  Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia.

Authors:  E L Prigogina; E W Fleischman; M A Volkova; M A Frenkel
Journal:  Hum Genet       Date:  1978-03-17       Impact factor: 4.132

6.  Nonrandom chromosome rearrangements in 27 cases of human myeloid leukemia.

Authors:  D Roźynkowa; J Stepień; J Kowalewski; A Nowakowski
Journal:  Hum Genet       Date:  1977-12-23       Impact factor: 4.132

7.  Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia.

Authors:  E W Fleischman; E L Prigogina; M A Volkova; M A Frenkel; N A Zakhartchenko; L N Konstantinova; G P Puchkova; S A Balakirev
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.